Labor induction information leaflets—Do women receive evidence-based information about the benefits and harms of labor induction?

Autor: Peter von Dadelszen, Susan Tohill, Julie Wade, Jennifer A. Hutcheon, Janet Scott, Marcus Green, James G. Thornton, Laura A. Magee, the WILL Pilot Trial Study Group

Publikováno v: Frontiers in Global Women's Health, Vol 3 (2022)

ObjectivesTo determine the extent to which a sample of NHS labor induction leaflets reflects evidence on labor induction.SettingAudit of labor induction patient information leaflets—local from WILL trial (When to Induce Labor to Limit risk in pregn

Externí odkaz: https://doaj.org/article/d59191a40bf14f028ab8e81929b906fb

Perinatal and 2-year neurodevelopmental outcome in late preterm fetal compromise: the TRUFFLE 2 randomised trial protocol

Autor: Neil Marlow, Luigi Raio, Roland Devlieger, Aris Papageorghiou, Rebecca Cannings-John, Christoph C Lees, Andrew Breeze, Andrew Sharp, Wessel Ganzevoort, Jim G Thornton, Julia Townson, Tanja Groten, Irene Cetin, Peter Lindgren, Federico Prefumo, Edward Mullins, Astrid Berger, Sofia Amylidi-Mohr, Cathrine Ebbing, Ladislav Krofta, Bianca Masturzo, Amarnath Bhide, Hans Wolf, Tiziana Frusca, Kurt Hecher, Tullio Ghi, Silvia Salvi, Wilfried Gyselaers, Raffaele Napolitano, MARK KILBY, Erich Cosmi, Claire Potter, Enrico Ferrazzi, Basky Thilaganathan, Dietmar Schlembach, Christine Morfeld, Bronacha Mylrea-Foley, Christina Ammari, Birgit Arabin, Eva Bergman, Caterina Bilardo, Julia Binder, Jana Brodszki, Pavel Calda, Andrej Černý, Elena Cesari, Andrea Dall'Asta, Anke Diemert, Torbjørn Eggebø, Ilaria Fantasia, Jenny Goodier, Patrick Greimel, Wassim Hassan, Constantin Von Kaisenberg, Alexey Kholin, Philipp Klaritsch, Silvia Lobmaier, Karel Marsal, Giuseppe M Maruotti, Federico Mecacci, Kirsti Myklestad, Eva Ostermayer, Jute Richter, Ragnar Kvie Sande, Ekkehard Schleußner, Tamara Stampalija, Herbert Valensise, Gerard HA Visser, Ling Wee, Andy Simm, Angela Ramoni, Barry Lloyd, Christopher Lloyd, Claudia Seidig, Danielle Thornton, Elena Mantovani, Emanuela Taricco, Emma Bertucci, Ferenc Macsali, Francesca Ferrari, Francesco D'Antonio, Giuseppe Cali, Giuseppe Rizzo, Ilaria Giuditta Ramezzana, Ioannis Kyvernitakis, Karen Melchiorre, Kristiina Rull, Laura Sarno, Liina Rajasalu, Louisa Jones, Makrina Savvidou, Maria Stefopoulou, Nicola Fratelli, Nishigandh Deole, Petra Pateisky, Pilar Palmrich, Ralf Schild, Sabina Ondrová, Sarah Gumpert, Serena Simeone, Silvia Visentin, Stefan Verlohren, Tatjana Radaelli, Tinne Mesens, Tiziana Fanelli, Yvonne Heiman, Zulfiya Khodzhaeva, Christoph Brezinka, Sanne Gordijn, Abin Thomas, Ligita Jokubkiene

Publikováno v: BMJ Open, Vol 12, Iss 4 (2022)

Introduction Following the detection of fetal growth restriction, there is no consensus about the criteria that should trigger delivery in the late preterm period. The consequences of inappropriate early or late delivery are potentially important yet

Externí odkaz: https://doaj.org/article/9633840173034347bd0a49beb46a528a

Ursodeoxycholic acid to reduce adverse perinatal outcomes for intrahepatic cholestasis of pregnancy: the PITCHES RCT

Autor: Lucy C Chappell, Jennifer L Bell, Anne Smith, Catherine Rounding, Ursula Bowler, Louise Linsell, Edmund Juszczak, Sue Tohill, Amanda Redford, Peter H Dixon, Jenny Chambers, Rachael Hunter, Jon Dorling, Catherine Williamson, Jim G Thornton

Publikováno v: Efficacy and Mechanism Evaluation, Vol 7, Iss 9 (2020)

Background: Intrahepatic cholestasis of pregnancy, characterised by maternal pruritus and raised serum bile acid concentrations, is associated with increased rates of stillbirth, preterm birth and neonatal unit admission. Ursodeoxycholic acid is wide

Externí odkaz: https://doaj.org/article/74e470fc9a114e9d8296bdc1c28ab4d6

Childbirth experience questionnaire 2: Validating its use in the United Kingdom

Autor: Kate F. Walker, Anna Dencker, Jim G. Thornton

Publikováno v: European Journal of Obstetrics & Gynecology and Reproductive Biology: X, Vol 5, Iss , Pp - (2020)

Objective: To validate the Childbirth Experience Questionnaire 2 (CEQ2) in the UK to see if it is an effective tool for evaluating labour experience. Study design: The CEQ2 and part of the Care Quality Commission Maternity Survey (2010) was sent to 4

Externí odkaz: https://doaj.org/article/cc8a2bf116874164973f2f7cbbec474a

Reduced fetal movement intervention Trial-2 (ReMIT-2): protocol for a pilot randomised controlled trial of standard care informed by the result of a placental growth factor (PlGF) blood test versus standard care alone in women presenting with reduced fetal movement at or after 36+ 0 weeks gestation

Autor: Lindsay Armstrong-Buisseret, Eleanor Mitchell, Trish Hepburn, Lelia Duley, Jim G. Thornton, Tracy E. Roberts, Claire Storey, Rebecca Smyth, Alexander E. P. Heazell

Publikováno v: Trials, Vol 19, Iss 1, Pp 1-13 (2018)

Abstract Background Forty percent of babies who are stillborn born die after 36 weeks gestation and have no lethal structural abnormality. Maternal perception of reduced fetal movement (RFM) is associated with stillbirth and is related to abnormal pl

Externí odkaz: https://doaj.org/article/8dd509bb7927431bb882b9440891f5d7